Physician

Richard B Culbert, MD

According to 2025 Medicare claims, Richard Culbert, MD (NPI: 1881663995) practices ophthalmology in the Midland, TX market, with the plurality of this provider's patient population coming from Midland, TX. This provider's primary affiliated billing organization is RICHARD B CULBERT MD PA (NPI: 1962450668; TIN: 200464294) and primary practice location at 79706-2205.

Culbert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 592 traditional Medicare patients, billed 15,648 HCPCS/CPT codes, and received $959,025 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 514 prescription claims across 176 beneficiaries totaling $30,609 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 18 records totaling $533. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $66,049 to $30,609. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$480K$959K2015 Medicare payment: $873,736 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $911,453 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $872,074 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $745,151 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $718,151 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $669,485 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $727,251 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $685,229 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $817,614 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $959,025 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201595810,324$873,736
201692710,134$911,453
20178889,152$872,074
201884510,673$745,151
20198179,344$718,151
20206715,979$669,485
20216336,323$727,251
20226006,367$685,229
202360511,072$817,614
202459215,648$959,025

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$88K2015 Drug cost: $66,049 (USD; Tot_Drug_Cst)2016 Drug cost: $69,667 (USD; Tot_Drug_Cst)2017 Drug cost: $67,646 (USD; Tot_Drug_Cst)2018 Drug cost: $81,648 (USD; Tot_Drug_Cst)2019 Drug cost: $87,990 (USD; Tot_Drug_Cst)2020 Drug cost: $77,459 (USD; Tot_Drug_Cst)2021 Drug cost: $60,964 (USD; Tot_Drug_Cst)2022 Drug cost: $51,387 (USD; Tot_Drug_Cst)2023 Drug cost: $50,299 (USD; Tot_Drug_Cst)2024 Drug cost: $30,609 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015159612$66,049
2016150623$69,667
2017157593$67,646
2018159650$81,648
2019197749$87,990
2020171669$77,459
2021176589$60,964
2022158480$51,387
2023169536$50,299
2024176514$30,609

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye167860$85
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more145173$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more5161,324$67
J7999Compounded drug, not otherwise classified93393$63
92134Imaging of retina4081,289$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium20683$6,953
Prednisolone AcetatePrednisolone Acetate1064,607$6,094
Timolol MaleateTimolol Maleate794,743$1,761
OfloxacinOfloxacin741,416$847
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat473,415$663

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.18$533Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard B. Culbert, MD?

Tedicare shows public-source Medicare data for Richard B. Culbert, MD (NPI 1881663995), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard B. Culbert, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard B. Culbert, MD?

Richard B. Culbert, MD is linked to RICHARD B CULBERT MD PA (billing NPI 1962450668) in the available physician profile data.

Does Richard B. Culbert, MD have Open Payments data?

Richard B. Culbert, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.